Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players√Ę‚ā¨‚ĄĘ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Request Free Sample
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.
Speak to Analyst

Contraceptive Drugs Market Size, Trends and Growth Outlook by Type [Oral Contraceptives (Combined Oral Contraceptive Pills and Progestogen-Only Pills), Topical Contraceptives, Contraceptive Injectables and others], Distribution Channel (Hospital & Clinics, Retail Pharmacy, Online Pharmacy and others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2030

ID: MRFR/Pharma/0768-HCR | 95 Pages | Author: Rahul Gotadki| April 2024

Contraceptive Drugs Market Overview

Contraceptive drugs market size is expected to reach USD 20.3 billion in 2030 at 7.1% CAGR during the forecast period 2022-2030. Contraceptives drugs are used to prevent pregnancy and are one of the methods used to control birth. Oral contraceptives are hormonal preparations that may contain combinations of the hormone’s estrogen and progestin or progestin alone.

The contraceptive drugs market is driven by factors such as the need to prevent the rising rate of unintended pregnancies and increasing awareness about contraceptive pills.

Additionally, the rise in government and NGO initiatives to promote contraceptive methods, easy use, and low costs of contraceptive drugs is anticipated to fuel the market growth.

For instance, according to the United Nations study ‚Äėglobal perspectives on unplanned pregnancies‚Äô, globally, more than 41% of the 208 million pregnancies that occur each year are unplanned.

On the other hand, side effects associated with the use of contraceptive drugs is projected to hamper the growth of the market during the assessment period.

Moreover, major companies in the market are involved in strategic acquisitions, collaborations, mergers, and new product launch to sustain their position in the market.

For instance, in April 2018, Mylan launched generic oral contraceptive Yaz tablets, which supported the company's growth in the global market.

The choice for modern methods, such as oral contraceptive pills, injectable contraceptives, and topical medicines, is changing away from traditional methods due to technological developments and a growing understanding of current contraceptive methods. Traditional treatments and medications have a lower success rate than contemporary approaches and provide only modest protection against STDs. As a result, the general public adopts and uses modern methods like sterilization, tablets, and other items at a rising rate. Through numerous campaigns and public awareness initiatives, non-profit organizations and local, regional, and national healthcare institutions increasingly focus on enhancing women's health and sexual wellness. These for-profit and non-profit groups encourage the use of contraception methods and raise public knowledge of them, including a rising preference for some of them.

The concentration on educating the general public about accessible contraceptive methods is growing due to growing worry over the world's population's rapid growth. This element has played a critical role in raising public understanding of the benefits of using contraception and the range of contraceptive alternatives, particularly in developing nations. The governments of various nations have also acknowledged the need to stop the rise in unintended pregnancies and have started several efforts to inform the public and stop the growth of unintended pregnancies and abortions. One of them is the use of contraceptive tablets. Acquiring and using contraceptives is a fundamental private right protected by the US Constitution. Additionally, domestic and international players' launch of OTC medications and other products resulted in higher adoption and fueled the market growth.

The main driver of the market expansion for contraceptive medications is the growing emphasis of major manufacturers and healthcare organizations on raising awareness of contraception options. Several issues, such as supply chain disruption, were blamed for this large revenue drop. Additionally, there have been substantial disruptions in many countries' contraception and family planning services. Increased prevalence of STDs, the number of unplanned pregnancies, and a rise in government activities are some factors driving the market's expansion. Unwanted pregnancies are a huge concern since they are growing more commonplace worldwide. As a result, the rise in unwanted pregnancies is predicted to increase demand for contraceptive medications and devices, which is predicted to accelerate market growth throughout the projection period.

Contraceptive Drugs Market Segmentation

The contraceptive drugs market has been segmented into type, distribution channel, and region.

The global market, based on type, the market is further segmented into oral contraceptives, topical contraceptives, contraceptive injectable, and others.

The oral contraceptives segment is further bifurcated into combined oral contraceptive pills and progestogen-only pills. This segment is expected to hold a major share of the market due to easy consumption, over the counter availability of oral contraceptives, and low costs.

Based on distribution channel, the global market is segmented into hospital & clinics, retail pharmacy, online pharmacy, and others.   

The retail pharmacy segment is anticipated to be the fastest-growing segment due to the increasing over the counter purchase of contraceptive drugs.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The contraceptive drugs market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada.

The European market has been sub-divided into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

 The market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.

The market in the Middle East & Africa has been divided into the Middle East and Africa.


Nearly sixty years after birth control became available in the U.S., the Food and Drug Administration (FDA) made a historic decision by approving the first over-the-counter, non-prescription birth control pill. The once-daily Opill will increase access to a secure way to use contraception in a reproductive health environment increasingly constrained by infrastructural shortages and bans on abortion. The decision was described as a "monumental step" in ensuring that people "can effectively limit unwanted pregnancies while controlling family planning" by the American Medical Association (AMA). The over-the-counter female pill will be made available at pharmacies thanks to the non-prescription approval, exactly as over-the-counter aspirin, condoms, and other medications. The pill is available to women and adults without a referral from a primary care doctor or gynecologist.

Key Players

The Key Players in the Global Market are Bayer AG (Germany), Pfizer Inc. (US), Teva Pharmaceutical Industries Ltd. (Israel), Merck & Co., Inc. (US), Mylan N.V.(US), Allergan Plc (Ireland), Agile Therapeutics (US), Piramal Enterprises Ltd. (India), GlaxoSmithKline PLC (UK), Johnson & Johnson (US), Novartis AG (Europe), and Sanofi (France).

Regional Market Summary

The market in the Americas is expected to dominate the global contraceptive drugs market due to the growing rate of unintended pregnancies and the need to prevent abortions in the region. Growing awareness about contraception in the US and Canada is expected to drive the market growth.

For example, according to an article by the National Center for Biotechnology Information, published in 2017, in the US, 45% of pregnancies are estimated to be unintended each year. Thus, to avoid abortions due to unwanted pregnancies, the use of contraceptive drugs is increasing.

The market in Asia-Pacific is expected to show a considerable amount of growth during the forecast period owing to the growing awareness about contraceptive pills and increasing government initiatives to promote contraceptive methods.

For example, in 2017, the Ministry of Health and Family Welfare of India launched two new contraceptives, a contraceptive pill ‚ÄėChhaya‚Äô and an injectable contraceptive MPA under the ‚ÄėAntara‚Äô program.

The market in Europe is expected to show a considerable amount of growth, owing to the increasing number of unintended pregnancies.

The market in the Middle East & Africa is projected to account for the least share of the market due to less awareness about contraceptive drugs in the region.

Contraceptive Drugs Market, by Type

  • Oral Contraceptives

  • Combined Oral Contraceptive Pills

  • Progestogen-Only Pills

  • Topical Contraceptives

  • Contraceptive Injectable

  • Others

Contraceptive Drugs Market, by Distribution Channel

  • Hospital & Clinics

  • Retail Pharmacy

  • Online Pharmacy

  • Others

Contraceptive Drugs Market, by Region

  • Americas

    • North America

      • US

      • Canada

    • Latin America

  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe

    • Eastern Europe

  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific

  • Middle East & Africa

    • Middle East

    • Africa

Intended Audience

  • Research and development (R&D) companies

  • Pharmaceutical & biotechnology companies

  • Government research institutes

  • Academic institutes and universities

  • Venture capitalists

Report Attribute/Metric Details
Market Size in 2030   USD 20.3 billion
  CAGR   7.1%
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD Billion)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type and Distribution Channel
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Bayer AG (Germany), Pfizer Inc. (US), Teva Pharmaceutical Industries Ltd. (Israel), Merck & Co., Inc. (US), Mylan N.V.(US), Allergan Plc (Ireland), Agile Therapeutics (US), Piramal Enterprises Ltd. (India), GlaxoSmithKline PLC (UK), Johnson & Johnson (US), Novartis AG (Europe), and Sanofi (France).
  Key Market Opportunities   increase to avoid unwanted pregnancies and their complication
  Key Market Drivers ·  rising rate of unintended pregnancies ·  increasing awareness about contraceptive pills

Frequently Asked Questions (FAQ) :

Contraceptive Drugs Market is predicted CAGR would be 7.1%.

The valuation was USD 20.3 billion by 2030.

The retail pharmacy segment would lead the market.

The oral contraceptives segment to lead the Contraceptive Drug Market.

The Americas have a maximum Contraceptive Drug Market.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Request Free Sample
Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.
Ask for Customization